Doug Kohrs appointed to Sequana Medical Board of Directors

2 years ago

Highly experienced US medtech leader brings more than 40 years’ experience Ghent, Belgium – 19 July 2022 – Sequana Medical…

180 Life Sciences Corp. Announces $6.5 Million Registered Direct Offering

2 years ago

PALO ALTO, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, “180 Life Sciences” or the…

ABVC Notes New Report That Estimates Global Retinal Surgical Instruments Market to Grow to $2.46 Billion by 2028

2 years ago

-- Growth to benefit ABVC’s Vitargus medical device product -- FREMONT, CA, July 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire…

Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs

2 years ago

Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is ready for inspectionNEWTON, Mass., July…

WIMI Hologram Academy: Vision-based Human-Computer Gesture Interaction Technology in Virtual Reality

2 years ago

HONG KONG, July 18, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

HTG Molecular Diagnostics Announces Amendment to Senior Loan Facility

2 years ago

TUCSON, Ariz., July 18, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing…

Ashvattha Therapeutics Announces Poster Presentation of Preclinical Data on Hydroxyl Dendrimer-Based PET Tracer [18F]OP-801 at the 2022 Alzheimer’s Association International Conference (AAIC)

2 years ago

– Scientific collaborators at Stanford University will present preclinical data on the sensitivity of [18F]OP-801 in comparison to TSPO-PET for…

Ring Therapeutics Announces Three Presentations at the 41st Annual Meeting of the American Society for Virology (ASV)

2 years ago

CAMBRIDGE, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Ring Therapeutics, a life sciences company founded by Flagship Pioneering to revolutionize…

PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors

2 years ago

Combination trial to be initiated in Q4 2022CRANBURY, N.J., July 18, 2022 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP; “PMV…